The growth of Viagra and its effect on the drug landscape presents a complex question for shareholders. While the early sales data were remarkable, the patent has expired, leading to a wave of off-brand alternatives https://dillanijms440465.dbblog.net/14703127/the-blue-pill-and-big-pharma-a-speculative-bet